300485SZSE

Announcement of Resolutions from the 13th Meeting of the 5th Board of Directors

Beijing Science Sun Pharmaceutical Co., Ltd.·

✨ AI Summary

The 13th meeting of the 5th Board of Directors of Beijing Saiseng Pharmaceutical Co., Ltd. was held on March 29, 2026. Key decisions included the approval of the 2025 annual financial report, profit distribution plan, and the appointment of an auditing firm for 2026. All resolutions received unanimous support from the board members present.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

I. Meeting Details

Beijing Saiseng Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") held the 13th meeting of its 5th Board of Directors on March 29, 2026, in the company meeting room. The meeting notice was sent to all directors on March 18, 2026, via communication. A total of 9 directors were supposed to attend, and all 9 directors were present. The meeting was chaired by Mr. Ma Xia, the chairman, and senior management attended the meeting. The meeting complied with the provisions of the Company Law of the People's Republic of China and other relevant laws, regulations, and the Company's Articles of Association, making the resolutions legal and valid.

II. Meeting Resolutions

After careful review and voting by all directors, the following proposals were approved:

  1. Proposal on the General Manager's 2025 Work Report
    The general manager reported to the board on the main work summary for 2025 and the work plan for 2026.
    Voting results: 9 votes in favor, 0 votes against, 0 abstentions.

  2. Proposal on the Board of Directors' 2025 Work Report
    The specific content of this proposal can be found in the Board of Directors' 2025 Work Report published on the information disclosure website designated by the China Securities Regulatory Commission. Independent directors Mr. Dai Yunping, Mr. Liu Feng, and Ms. Song Yanheng submitted their annual reports to the board and will present them at the 2025 annual shareholders' meeting.
    Voting results: 9 votes in favor, 0 votes against, 0 abstentions. This proposal requires submission to the shareholders' meeting for review.

  3. Proposal on the 2025 Financial Settlement Report
    The specific content of this proposal can be found in the 2025 Financial Settlement Report published on the information disclosure website designated by the China Securities Regulatory Commission. This proposal has been reviewed and approved by the company's audit committee.
    Voting results: 9 votes in favor, 0 votes against, 0 abstentions. This proposal requires submission to the shareholders' meeting for review.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing